False negative anti-HIV-1 HIV-2 ELISAs in acute HIV-2 infection

被引:16
|
作者
Christiansen, CB [1 ]
Jessen, TE [1 ]
Nielsen, C [1 ]
StaunOlsen, P [1 ]
机构
[1] HOLBAEK CENTRALSYGEHUS,DEPT CLIN CHEM,COPENHAGEN,DENMARK
关键词
D O I
10.1111/j.1423-0410.1996.tb01312.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since HIV-2 was isolated in 1986, only 1 case of acute HIV-2 infection has been reported. We have identified another patient with primary HIV-2 infection, Follow-up samples were requested from the patient due to discrepant results, The HIV-2 infection was confirmed with HIV-2-specific proviral DNA amplification by PCR. The HIV-2 seroconversion panel obtained was used to evaluate the sensitivity of both combined and specific ELISAs currently in use in Europe, and to investigate the Western-blot patterns on both HIV-1- and HIV-2-specific Western blots. The window period was determined to be less than 37 days with the most sensitive assays. A remarkable difference in sensitivity to HIV-2 antibodies in acute HIV-2 infection was found in combined HIV-1/HIV-2 ELISAs. Three out of the 4 combined sandwich ELISAs appeared to be less sensitive than the indirect ELISAs in HIV-2 seroconversion, leading to a prolonged window period. One HIV-2-specific ELISA was also negative on the first sample, but positive on the second sample. In the HIV-2 Western blot, early reaction with HIV-2-specific env and gag proteins was seen, whereas the HIV-1 Western blot on the first sample revealed gag (p24, p55) reactivity only.
引用
收藏
页码:144 / 147
页数:4
相关论文
共 50 条
  • [1] An anti-HIV-1 rO/HIV-2 assay on the bayer ADVIA® centaur™.
    Freeman, J
    Patel, M
    Gourov, A
    Baker, L
    [J]. CLINICAL CHEMISTRY, 2001, 47 (06) : A96 - A96
  • [2] MULTISITE EVALUATION OF 4 ANTI-HIV-1/HIV-2 ENZYME IMMUNOASSAYS
    SILVESTER, C
    HEALEY, DS
    CUNNINGHAM, P
    DAX, EM
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1995, 8 (04) : 411 - 419
  • [3] Infection with HIV-2
    Bock, PJ
    Markovitz, DM
    [J]. AIDS, 2001, 15 : S35 - S45
  • [4] HIV-2 INFECTION
    STILLE, W
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, 112 (24) : 978 - 978
  • [5] MONITORING BLOOD-DONORS FOR HIV-2 INFECTION BY TESTING ANTI-HIV-1 REACTIVE SERA
    BUSCH, MP
    PETERSEN, L
    SCHABLE, C
    PERKINS, H
    [J]. TRANSFUSION, 1990, 30 (02) : 184 - 187
  • [6] SYNTHESIS, ANTI-HIV-1 AND HIV-2 ACTIVITY OF NAPHTHALENEDISULFONIC ACID-DERIVATIVES
    MOHAN, P
    SINGH, R
    BABA, M
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 131 - MEDI
  • [7] Dual infection with HIV-1 and HIV-2
    Clarke, JR
    Sohi, DK
    Maniar, JK
    Udwadia, Z
    Mitchell, DM
    [J]. THORAX, 1997, 52 (06) : 587 - 588
  • [8] EVALUATION OF THE RELIABILITY OF 6 CURRENT ANTI-HIV-1/HIV-2 ENZYME IMMUNOASSAYS
    WEBER, B
    MOSHTAGHIBORONJENI, M
    BRUNNER, M
    PREISER, W
    BREINER, M
    DOERR, HW
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1995, 55 (01) : 97 - 104
  • [9] 13 CURRENT ANTI-HIV-1/HIV-2 ENZYME IMMUNOASSAYS - HOW ACCURATE ARE THEY
    MCALPINE, L
    GANDHI, J
    PARRY, JV
    MORTIMER, PP
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1994, 42 (02) : 115 - 118
  • [10] Characteristics of a South London cohort of adults with HIV-2 and HIV-1/HIV-2 dual infection
    Sivaraj, V.
    Mabonga, E.
    Davies, O.
    [J]. HIV MEDICINE, 2018, 19 : S130 - S131